The Global Fund Board has approved funding for 31 Round 9 proposals that had been recommended by the Technical Review Panel (TRP), but for which funding was not formally approved at the Board's in-person meeting in November 2009. At the time of the Board meeting, the Global Fund did not have enough money to approve all 85 proposals recommended by the TRP. Consequently, the Board formally approved all 54 proposals rated Category 1 or Category 2, but approved only "in principle" the 31 proposals rated Category 2B. The 31 proposals will cost $720 million over the first two years. This amount is prior to the "efficiency savings" (i.e., cost-cutting) mandated by the Board for all approved Round 9 proposals. These savings should amount to at least 10% of the $720 million total, though the percentage reduction for individual grants will vary. The Global Fund said that additional funding sufficient to approve the 31 proposals came from several sources, in particular confirmation of additional pledges by some donors; and a reduction in the amounts forecasted to be required for Phase 2 and rolling continuation channel (RCC) renewals in 2010. Of the 31 proposals formally approved by the Board, 29 were from CCMs and two were from regional organisations. The proposals are listed in the following table.

Applicant	Component		Applicant	Component
FROM CCMS			Montenegro	HIV
Angola	TB		Mozambique	HIV (disease part)
Belize	HIV (disease part + HSS part)		Nicaragua	Malaria
Bosnia & Herzegovina	TB		Nigeria	TB
Central African Republic	TB		Sri Lanka	HIV (disease part + HSS part)
China	TB (disease part + HSS part)		Tanzania	Malaria
Columbia	HIV		Turkmenistan	TB (disease part)
Congo (Democratic Republic of)	TB (disease part + HSS part)		Vietnam	TB
Congo (Republic of)	HIV		Yemen	TB
Djibouti	Malaria		FROM REGIONAL ORGANISATIONS
Ethiopia	TB (HSS part)		COPRECOS LAC (re Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela)	HIV
Gambia	TB
Guinea-Bissau	TB
Haiti	TB
India	HIV
India	Malaria
Iraq	TB		SADC (re Angola, Botswana, Congo (Democratic Republic), Lesotho, Malawi, Mauritius, Mozambique, Namibia, Seychelles, South Africa, Swaziland , United Republic of Tanzania, Zambia, Zimbabwe)	HIV
Kenya	TB
Kosovo	TB
Kyrgyz Republic	TB
Moldova	TB

For information on the budgets of individual proposals, see "Round 9 results, by country" in GFO Issue 110 at www.aidspan.org/gfo.